2026-526293-16-00招募中1 期
GRT-2U101: A randomized, double-blind, placebo-controlled single and multiple ascending dose study to evaluate safety, tolerability, and pharmacokinetics/pharmacodynamics of GRT-002 in healthy volunteers and patients with chronic spontaneous urticaria after single or multiple intravenous or subcutaneous dosing of GRT-002 (BASALT trial).
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 73
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Kerstin Renner
Scientific
Granite Bio AG
研究点 (2)
Loading locations...
相似试验
招募中
1 期
GRT-1C102: A randomized, double-blind, placebo-controlled dose escalation study to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of GRT-001 after subcutaneous administrations to healthy subjects (MONOSqut trial).Ulcerative colitis2025-524328-24-00Granite Bio AG40
尚未招募
2 期
A Clinical Trial of GRT7040 in Adults With Acute Pain Following BunionectomyAcute PainBunionectomyNCT07807644Grünenthal GmbH400
招募中
不适用
A Phase 2 study of naldemedine in participants with constipation associated with Parkinson's diseasejRCT203126006040
撤回
1 期
A phase 1, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of VNA-318 in healthy male subjects2024-512106-26-00Vandria SA96
招募中
不适用
A Phase IIb Study of the Efficacy and Safety of AZD5148 to Prevent Recurrence of Clostridioides difficile InfectionClostridioides difficile infectionjRCT203125057910